Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/38809
Title: Derivatives of Pyrazolo[1,5-a][1,3,5]Triazines as Enzyme Inhibitors with Potential Therapeutic Value
Authors: SUN LINGYI
Keywords: Pyrazolo[1,5-a][1,3,5]triazines,Thymidine phosphorylase,Enzyme inhibitor,Antiangiogenesis
Issue Date: 24-Jan-2013
Source: SUN LINGYI (2013-01-24). Derivatives of Pyrazolo[1,5-a][1,3,5]Triazines as Enzyme Inhibitors with Potential Therapeutic Value. ScholarBank@NUS Repository.
Abstract: Thymidine phosphorylase (TP) is an enzyme that promotes tumour growth and metastasis thus is an attractive druggable target. The goal of this project was to develop new TP inhibitors based on the pyrazolo[1,5-a][1,3,5]triazine scaffold. A total of 90 compounds containing the pyrazolo[1,5-a][1,3,5]triazine scaffold were synthesized. The most potent compound of the 1,3-dihydro-pyrazolo[1,5-a][1,3,5]triazin-2-thioxo-4-one series showed an IC50 value of 40nM, and it was 800 times more potent than the lead compound 7DX. It was found to be a non-competitive inhibitor, indicating that it might interact at an allosteric site. The most potent compound of the 2-(5-chloro-1,3-dihydropyrimidin-2,4-dioxo-6-ylmethylthio)pyrazolo[1,5-a][1,3,5]triazin-4(3H)-one series showed an IC50 value of 0.36?M. It was found to be a mixed-type inhibitor, indicating that it might interact at both the substrate site and the allosteric site. In addition, a total of 9 compounds showed suppressive effects on the expression of the angiogenic factor MMP-9, thus they might possess antiangiogenesis potential.
URI: http://scholarbank.nus.edu.sg/handle/10635/38809
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
SunL.pdf1.14 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

141
checked on Dec 11, 2017

Download(s)

387
checked on Dec 11, 2017

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.